he amount of money spent on medicines by each American this year will decline slightly to $800 per person and spending will continue at this level through 2022, thanks to moderating price hikes and the loss of patent protection on many drugs, a new report forecasts.

Moreover, 2018 will mark the third consecutive year in which U.S. per capita spending on pharmaceuticals will fall, reflecting discounts and rebates extracted from drug makers and overall slowing spending growth, according to the IQVIA Institute for Human Data Science. Overall, spending will rise 4 percent to 7 percent through 2022 on a compounded annual growth rate.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.